Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
211 - 220 of 892 results
  • CB1-Dependent Long-Term Depression in Ventral Tegmental Area GABA Neurons: A Novel Target for Marijuana | Journal of Neuroscience
    The VTA is necessary for reward behavior with dopamine cells critically involved in reward signaling. Dopamine cells in turn are innervated and regulated by neighboring inhibitory GABA cells. Using whole-cell electrophysiology in juvenile-adolescent GAD67-GFP male mice, we examined excitatory plasticity in fluorescent VTA GABA cells. A novel CB1-dependent LTD was induced in GABA cells that was dependent on metabotropic glutamate receptor 5, and cannabinoid receptor 1 (CB1). LTD was absent in CB1 knock-out mice but preserved in heterozygous littermates. Bath applied Δ9-tetrahydrocannabinol depressed GABA cell activity, therefore downstream dopamine cells will be disinhibited; and thus, this could potentially result in increased reward. Chronic injections of Δ9-tetrahydrocannabinol occluded LTD compared with vehicle injections; however, a single exposure was insufficient to do so. As synaptic modifications by drugs of abuse are often tied to addiction, these data suggest a possible mechanism for the addictiv...
    Nov 8, 2017 Lindsey Friend
  • Abstract
    CBD effects on measures of anxiety and depression in a preclinical model of post traumatic stress disorder
    The cannabis industry in the US has experienced tremendous growth in recent years, in part due to a more permissive regulatory environment. The availability of cannabidiol (CBD) in a variety of commercial products has fueled consumer experimentation as ...
    Oct 23, 2019
  • Abstract
    Cannabidiol reverses stress-induced impairment of conditioned fear in rats: Involvement of serotonergic, cannabinoid and nitrergic systems
    Aims: To test if cannabidiol (CBD), a non-psychotomimetic component of Cannabis sativa with anxiolytic properties, could prevent the changes in fear processing induced by severe stress. We also investigated possible mechanisms of this effect. Methods: M...
    Oct 23, 2019
  • Abstract
    Intravenous self-administration of Δ9-tetrahydrocannabinol by adolescent rats alters reinstatement and working memory behaviors in adulthood
    Adolescence is a period of brain development that often coincides with initiation of drug use, including Δ9-tetrahydrocannabinol (THC), the primary psychoactive component of marijuana. This exposure can alter development on a neuronal and molecular leve...
    Oct 23, 2019
  • Abstract
    SITES AND MECHANISMS OF PERIPHERAL CHEMOSENSITIVITY AFTER CAROTID (CBD) AND/OR AORTIC DENERVATION IN PIGLETS.
    Ventilatory (VE) responses to NaCN injections in the descending aorta of CBD piglets demonstrate plasticity in peripheral chemosensitivity (J.Appl.Physiol. 87:2128-2135, 1999). Further, immunostaining shows an increase in serotonin (5-HT) in the subendothelial and adventitia layers of the same aortic areas after CBD (FASEB J. 15(4):A422, 2001). The present study assesses whether the peripheral chemosensitivity after CBD in the aorta requires 5-HT and if chemosensitivity remains after combined aortic and carotid body denervation (AOD+CBD). In 25 piglets, peripheral chemosensitivity (VE responses) was assessed 3 weeks after carotid and/or aortic, or sham denervation by injections of 6.3 mM NaCN (0.05mg.kg-1) into the jugular vein, common carotid arteries and descending aorta, before (control) and after the IV administration of the 5-HT blockers, metoclopramide (MCP), and methiothepin (MTN). Venous NaCN VE responses did not differ among all groups (p = 0.531) whereas carotid responses were present in SHAM and...
    Nov 13, 2001
  • Abstract
    Cannabidiol regulates mesolimbic dopamine system transmission through peroxisome proliferator-activated receptor gamma signaling in the nucleus accumbens
    Cannabis contains two compounds that produce opposite effects. Delta-9-tetrahydrocannabiol (THC), the main psychotropic component of cannabis, has been shown to induce anxiety and schizophrenia-like symptoms. In contrast, cannabidiol (CBD), the non-psyc...
    Nov 7, 2018
  • Abstract
    Effects of tetrahydrocannabinol treatment on brain metabolism and inflammation in a mouse model of sporadic Alzheimer’s disease
    Limited therapeutic effects of current Alzheimer treatments highlight the need for new research approaches. The endocannabinoid system plays a role in neuroinflammation and memory formation and therefore addresses major pathological hallmarks of Alzheim...
    Nov 6, 2018
  • Abstract
    Adolescent exposure to THC alters mean diffusivity in adult rat brain regions associated with learning and emotion
    Cannabis use among adolescents is expected to increase as its use becomes legal in a growing number of states and countries. Despite this growth, little is known about the lasting impact of its chemical constituents on brain development. In this study, ...
    Nov 5, 2018
  • Abstract
    A chronic low dose of delta-9-tetrahydrocannabinol restores cognitive function in old mice by histone acetylation
    Brain aging is accompanied by a number of cellular and molecular changes that may ultimately lead to cognitive deficits. One of these changes is a decline in the activity of the endocannabinoid system characterised by diminished 2-arachidonoylglycerol l...
    Nov 4, 2018
  • Abstract
    Behaviorally disruptive doses of δ-9-tetrahydrocannabinol do not affect cell proliferation in the adult mouse dentate gyrus.
    Marijuana is one of the most widely abused illicit drugs and is known to cause significant cognitive impairments. It has been hypothesized that marijuana may preferentially target neurons in the hippocampus because of the abundance of cannabinoid receptors present in this structure. While there is no clear evidence of neuropathology in vivo, suppression of brain mitogenesis, and ultimately neurogenesis, may provide a sensitive index of marijuana’s more subtle effects on neural mechanisms subserving cognitive functions. To this end, we examined the effects of different doses and treatment regimens (both acute and chronic) of delta-9-tetrahydrocannabinol (THC), the main active ingredient in marijuana, on cell proliferation in the mouse dentate gyrus (DG), using the bromodeoxyuridine method (BrdU; 200 mg/kg, i.p; 2 h survival time). Administration of THC produced marked dose- and time-dependent behavioral sedation and catalepsy. The number of BrdU labeled cells was not significantly changed from vehicle contr...
    Nov 16, 2005
  • Previous
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience